ArticleMedicine2025
Client risk segmentation to identify and respond to the differentiating characteristics of clients with advanced HIV disease in Kyrgyzstan: A retrospective analysis of routine program data.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Global prevalence of advanced HIV disease in healthcare settings: a rapid review.Journal of the International AIDS Society · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The World Health Organization recommends a comprehensive package of interventions to screen for, prevent, and treat advanced human immunodeficiency virus (HIV) disease (AHD). However, implementation remains suboptimal, particularly among key populations. We conducted a retrospective analysis of routine clinical data from HIV treatment sites supported by the PEPFAR-funded USAID Meeting Targets and Maintaining Epidemic Control (EpiC) Kyrgyzstan project. The analysis included baseline demographic and clinical characteristics of newly diagnosed adult persons living with HIV who initiated antiretroviral therapy between September 1, 2020 and December 31, 2021, at EpiC-supported sites. AHD was defined as a CD4 cell count <200 cells/mm or meeting the World Health Organization criteria for stage 3 or 4 disease. We used bivariate and multivariable logistic regression models to examine associations between client characteristics and AHD. Among 240 clients, 79 (32.9%) presented with AHD. In bivariate analysis, AHD was significantly associated with age ≥ 30 years (OR = 4.15; CI = 1.93-8.92); being widowed or divorced (OR = 3.21; CI = 1.78-5.78); or being a person who injects drugs, a sexual partner of persons living with HIV or client of female sex workers (OR = 4.44; CI = 2.13-9.25). In multivariable analysis, all except age remained significant predictors. Routine program data can help identify high-risk groups for AHD. Segmentation based on client characteristics may inform strategies to promote earlier HIV testing and tailored interventions for prevention and care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.